I'm LongbridgeAI, I can summarize articles.M&A activity and massive capital expenditures dominated recent corporate action. Nuvei's $2.75 billion acquisition of Payoneer and Fluor's massive project backlog highlight industry momentum, while Sonim and Willdan pivot operations.
M&A activity and massive capital deployment are driving structural shifts across multiple sectors. Nuvei's $2.75 billion all-cash buyout of Payoneer Global (PAYO.US) anchors the recent deal flow, taking the cross-border payment firm private after a robust period where its B2B transaction volume surged 44% early in 2026.
Heavy infrastructure and engineering players are securing massive project pipelines and adjusting their portfolios. Fluor Corporation (FLR.US) reported a $26.9 billion backlog and a 9% bump in Q2 revenue to $4.3 billion, bolstered by the $175 million divestiture of its Mexican joint venture. In the regulated utility space, Public Service Enterprise Group (PEG.US) committed to a sweeping $22.5 billion to $25.5 billion capital investment plan through 2030, riding on adjusted Q2 earnings of $0.86 per share.
Mid-cap firms are leaning heavily into strategic pivots and bolt-on acquisitions. Willdan Group (WLDN.US) snapped up KCS Corporation and Burton Energy Group, raising its FY26 net revenue guidance to as much as $430 million. Sonim Technologies (SONM.US) has taken a sharper operational turn, rebranding to DNA X to focus purely on digital asset management while narrowly regaining compliance with Nasdaq's $2.5 million minimum equity requirement.
Life sciences and med-tech operators remain highly invested in R&D and specialized facility build-outs. Merck KGaA (MKKGY.US) bumped its full-year guidance and opened a €25 million testing facility in Germany to meet biopharma market demand. Corvus Pharmaceuticals (CRVS.US), armed with over $210 million in liquidity, is advancing Phase 3 trials for its lead asset soquelitinib and recently injected $5 million into its Chinese partner. Meanwhile, NeuroOne Medical Technologies (NMTC.US) posted a 16% revenue increase to $2 million as it preps its thin-film electrode tech for broader human applications.
At the distressed tail end of the spectrum, HVI Cat Canyon (HVIIR.US) remains bogged down by deep environmental liabilities, hit with a $65 million court-ordered penalty for legacy oil spills and mandated to plug 210 wells following its bankruptcy. GEV Car (GEVC.US) continues to operate with extremely limited public visibility, offering virtually no material operational or financial updates.